DNA X INC
SONMNASDAQ🏆 #3837 by market capUS Equity
$678.47▼ $47.90 (−7.06%)
Simulated price1h—
24h▼ 7.1%
7d—
14d—
30d—
1y—
🏦Market Cap
$5M
Small Cap
📈Revenue Growth (YoY)
-53.0%
Declining
📊Gross Margin
18.3%
Thin
💵FCF Margin
1.4%
Thin
⚖️P/S Ratio
0.1x
Cheap
Otter Score
43
Weak
No chart data available for SONM.
Trading Snapshot
- Day Range
- $673.76 – $683.82
- 52-Week Range
- $2.52 – $16.97
- Volume
- $2.95B
- Avg Volume
- $3.35B
- Shares Outstanding
- 1.5M
- Next Earnings
- Sep 29, 2026
Fundamentals Snapshot
- Annual Revenue
- $60M
- Last Q Revenue
- $14M
- P/E Ratio
- —
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-13.96
- Dividend Yield
- —
Why Investors Own SONM
- ✓High-growth profile — revenue up +22.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 41% gross margin and 25% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$60M▲ +21.1% YoY
Gross Margin (TTM)
41.0%▲ +1.9% YoY
Operating Income (TTM)
$9M▲ +21.1% YoY
Free Cash Flow (TTM)
$15M▲ +21.1% YoY
About DNA X INC
A company profile for DNA X INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
43/100
Analyst Price Target
ⓘAverage Target
$849.70
▲ +25.2% Upside
High Target$1,029.16
Low Target$784.68
Based on 16 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
DNA X INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift SONM price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Reuters·1d ago
DNA X INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.